We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close update

10 Feb 2020 07:00

RNS Number : 4117C
Watchstone Group PLC
10 February 2020
 

Watchstone Group plc

 

("Watchstone" or the "Group")

 

Pre-close update

 

Watchstone Group plc (LON:WTG) today issues a pre-close update ahead of its results for the year ended 31 December 2019.

 

During 2019, the Board continued its work to simplify the Group, resolve legacy issues, reduce costs and to commence the process for returning further capital to shareholders.

 

As announced on 7 February 2020, our Healthcare Services division in Canada was sold for an initial cash consideration of Canadian $36.2m (£20.8m) on a cash and debt free basis with up to a further C$0.8m (£0.5m) conditional on the business generating target revenues in the first year after its acquisition.

 

A number of commercial disputes were resolved in the year, the most significant of which was the High Court claim issued by Slater and Gordon (UK) 1 Limited ("S&G"). As announced on 21 October 2019, the settlement provided for £11m of the £50m held in escrow to be released to S&G with the balance of £39m and accrued interest being released to Watchstone.

 

Cash and term deposits on 31 December 2019 (excluding cash within businesses classified as held for sale) totalled £71.6m. Total cash following completion of the sale of the Healthcare Services division, is approximately £90m representing approximately 195 pence per share.

 

Capital return

 

Watchstone will now proceed with plans for a further Court approved, capital repayment to shareholders and further details will be announced in due course. Subject to shareholder approval, completion of the necessary working capital and creditor analysis (including contingent creditors) and the Court timetable, the current plan is to return at least £50m (representing at least 110p per share) before the end of June 2020. The timetable is anticipated to be slightly longer than usual given the need to complete the audit in advance of the return.

 

As further matters are resolved, the Company will seek to return additional cash to shareholders.

 

ingenie

 

Following the sale of the Healthcare Services division, Watchstone now retains one remaining operating business, ingenie. Consistent with our announcement at the half year, ingenie's retail business continued to face difficult market conditions in 2019, but significant changes have been made to increase competitiveness which are now bearing fruit with daily new policy sales at their highest levels for a number of years.

 

In November 2019, ingenie successfully launched its new self-fit proposition making its offering ever more competitive.

 

Legacy matters

 

The SFO investigation continues and we are cooperating fully. It remains the only regulatory inquiry to which the Group is subject.

 

Whilst we understand that the previously threatened class action litigation first announced in September 2015 has been abandoned, a firm purporting to act for a group of twelve individuals (some of whom participated in the original threatened litigation) has recently written a "Notice of intended claim" to the Company ("Notice"). The Notice relates to potential pursuit of a claim arising under section 90A and Schedule 10A of the Financial Services and Markets Act 2000. However, it provides no information to support the validity or valuation of the individual prospective claimants' claims, which they would be required to prove in due course in any litigation. The Company will vigorously defend all such claims if so brought.

 

2020 outlook

 

The Group's stated strategy remains to ultimately divest of its operating businesses, resolve all legacy issues and return as much capital as possible to shareholders.

 

The Board hopes that 2020 will see significant further progress to the final resolution of the Group's historic matters and a substantial return of capital to shareholders in at least one distribution (as referred to above).

 

For further information:

Watchstone Group plc 

 

 

Tel: 03333 448048

WH Ireland Limited, Nominated Adviser and broker

 

Chris Hardie

Lydia Zychowska

Tel: 020 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKZGGZLLNGGZM
Date   Source Headline
8th Dec 20147:00 amRNSTrading update
5th Dec 20147:00 amRNSIssue of shares
28th Nov 20147:00 amRNSResponse to speculation
26th Nov 20144:33 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
26th Nov 20147:00 amRNSDirector Shareholding
25th Nov 20144:40 pmRNSSecond Price Monitoring Extn
25th Nov 20144:35 pmRNSPrice Monitoring Extension
20th Nov 20147:00 amRNSResponse to speculation
18th Nov 20147:00 amRNSDirectorate Change
17th Nov 20147:51 amRNSResignation of joint broker
13th Nov 201411:00 amRNSNotification of Major Interest in Shares
11th Nov 20147:00 amRNSDirector Shareholding
10th Nov 201411:34 amRNSDirector Shareholding
10th Nov 201410:59 amRNSDirector Shareholding
10th Nov 20147:00 amRNSFurther re Director Share Purchases and Correction
7th Nov 201410:31 amRNSDirector Shareholding
5th Nov 20141:46 pmRNSDirector Share Purchases
31st Oct 20143:51 pmRNSDirector/PDMR Shareholding
29th Oct 20142:57 pmRNSDirector/PDMR Shareholding
28th Oct 20142:11 pmRNSDeath of Quindell Non-Executive Vice Chairman
21st Oct 20147:00 amRNSMajor Insurer 5 Year Contract Win
17th Oct 201412:44 pmRNSDirector/PDMR Shareholding
16th Oct 20147:00 amRNSDirector/PDMR Shareholding
15th Oct 20147:58 amRNSDirector/PDMR Shareholding
13th Oct 20147:00 amRNSQ3 Trading Statement
29th Sep 20147:00 amRNSStatement re Share Price Movement
9th Sep 20147:00 amRNSCourt judgement won against Gotham City Research
2nd Sep 20147:00 amRNSUpdate on Connected Car Solutions
21st Aug 20147:07 amRNSExecutive Appointment
21st Aug 20147:00 amRNSInterim Results
6th Aug 201412:38 pmRNSTrading Update
14th Jul 20147:01 amRNSNon-Executive Director Appointment
14th Jul 20147:00 amRNSPre-Close Statement and Trading Update
1st Jul 20147:00 amRNSNotification of Major Interest in Shares
30th Jun 20147:00 amRNSNotification of major interest in shares
27th Jun 20147:01 amRNSDirector/PDMR Shareholding
27th Jun 20147:00 amRNSH1 Results Announcement Date
26th Jun 20147:00 amRNSDirector/PDMR Shareholding
25th Jun 20141:16 pmRNSDirector/PDMR Shareholding
24th Jun 20147:00 amRNSDirector/PDMR Shareholding
23rd Jun 20147:00 amRNSIssue of shares for PT Health investment
20th Jun 20143:07 pmRNSTotal Voting Rights
19th Jun 20144:58 pmRNSBoard change
19th Jun 20143:20 pmRNSResult of AGM
19th Jun 20147:00 amRNSAGM Statement and Proposed Board Changes
17th Jun 20145:42 pmRNSLegal Services Investor Teach-In
11th Jun 201410:29 amRNSFurther Update on Premium Listing
9th Jun 20147:00 amRNSUpdate on Premium Listing
30th May 20144:35 pmRNSPrice Monitoring Extension
23rd May 20147:00 amRNSPosting of Annual Report and Investor Teach-In

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.